Shrimp aquaculture has been dramatically affected by many pathogenic diseases, mainly caused by five viruses: IHHNV, YHV, TSV, WSSV, and IMNV. Here we provide a state-of-the-art overview of these shrimp viruses, with emphasis on distribution, pathology, morphology, and genomic organization, in addition to current diagnostic methods and intervention practices.
INTRODUCTION
In Latin American, Brazil is the third largest shrimpproducing country, being the States of Rio Grande do Norte, Ceará, and Pernambuco the major producers. However, despite the expressive growth in the Brazilian and world shrimp farming industry in the last decades, several pathogenic diseases have been reported to cause substantial economic losses. To date, more than twenty viral diseases have been reported to affect shrimp and prawns, and five viral pathogens of penaeid shrimp are currently listed by the World Organization for Animal Health (16) . In this review, the distribution and biological characteristics of these five most significant viruses are profiled: infectious hypodermal and hematopoietic necrosis virus (IHHNV), yellow head virus (YHV), Taura syndrome virus (TSV), white spot syndrome virus (WSSV), and infectious myonecrosis virus (IMNV). The most valid diagnoses and interventions to avoid and contain viral dissemination are also further reviewed.
MAJOR SHRIMP VIRUSES

Infectious hypodermal and hematopoietic necrosis virus (IHHNV):
The first widespread viral epizootic to seriously affect the commercial penaeid shrimp industry was IHHNV, also named Penaeus stylirostris densovirus (PstDNV), first reported in blue shrimps from Hawaii in 1980 (10) .
IHHNV has been identified in many other Pacific islands, as well as in the Americas from Peru to Mexico, East and Southeast Asia, Middle East, and Australia (16) . IHHNVrelated sequences have been found inserted into the genome of P. monodon from India, Africa, and the Western Indo-Pacific region including Madagascar, Mauritius, and Tanzania.
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Shrimp aquaculture due to viral diseases vaccines or RNAi therapy must be better studied to guarantee the feasibility and cost-effectiveness of these interventions. In this scenario, the shrimp farming industry will evolve in a sustainable and safe system, reducing losses in production due to viral diseases.
